MétaCan
Menu
Back to cohort
Record W2587344728 · doi:10.1093/ecco-jcc/jjx002.750

P626 Ustekinumab for the treatment of perianal fistulas in patients with Crohn's disease

2017· article· en· W2587344728 on OpenAlexaffabout
Robert Battat, Talat Bessissow, Matthew Strohl, Uri Kopylov, Alain Bitton, A Cohen, Ernest G. Seidman, Waqqas Afif

Bibliographic record

VenueJournal of Crohn s and Colitis · 2017
Typearticle
Languageen
FieldMedicine
TopicAnorectal Disease Treatments and Outcomes
Canadian institutionsJewish General HospitalMcGill University Health Centre
Fundersnot available
KeywordsUstekinumabCrohn's diseaseMedicineDermatologyGastroenterologyCrohn diseaseDiseaseInternal medicineAdalimumab

Abstract

fetched live from OpenAlex

Background: Ustekinumab (UST), an interleukin-12/23p40 inhibitor, is effective in Crohn's disease (CD). Little is known on its efficacy in perianal fistulizing disease. To date, perianal outcomes using UST have been reported in only 18 patients. We report on the efficacy of UST on perianal fistulizing disease in CD. We also describe UST trough concentration, clinical, biomarker and endoscopic response in CD patients with perianal fistulas. Methods: Anti-TNF refractory CD patients treated with UST (2013–2015) at the McGill University Health Centre were recruited. All patients were induced with UST 90mg SC at week 0, 1, 2 then maintained with UST 90mg SC every 4 or 8 weeks. At 6 months 77.4% were receiving UST every 4 weeks. The primary endpoint was >50% reduction from baseline in the number of draining fistulas. The secondary endpoint was closure of all fistulas. Outcomes were assessed for longitudinal patients and cross sectional patients ≥6 months. A combined cohort was analyzed at ≥6 months, when available. UST and UST antibody concentrations were assessed using a liquid phase assay (HMSA, Prometheus Laboratories, San Diego, CA, USA). Results: Sixty-two patients were recruited. 17 patients had a history of perianal fistulizing disease. 6 patients had actively draining fistulas prior to initiating UST. At ≥6 months, 66% (4/6) of patients had a >50% reduction from baseline in the number of draining fistulas, and 33% (2/6) patients had closure of all fistulas. At ≥6 months, of the 6 patients who had active fistulas at commencement of UST, 3/6 (50%) attained clinical response while 2/6 (33%) attained clinical remission as determined by HBI assessment (HBI<5). 2/6 (33%) achieved steroid free clinical remission. Endoscopic response was attained in 3/6 (50%) patients while 2/6 (33%) attained endoscopic remission. Mean UST trough concentration at ≥ week 26 was 4.85 ug/ml. In those with >50% reduction in draining fistulas (n=4) mean UST trough concentrations were 5.0 ug/ml compared to 4.6 ug/ml in those without (n=2). Conclusions: UST was effective in achieving reduction in perianal fistulas in a small series of anti-TNF refractory CD patients. Given the limited information on this subject, this series adds to the existing data on response of perianal fistulas with UST. However, larger studies are required to confirm these findings.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.014
GPT teacher head0.278
Teacher spread0.264 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations8
Published2017
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Crohn s and ColitisSame topicAnorectal Disease Treatments and OutcomesFrench-language works237,207